AzTrials
AzTrials

Computer-Assisted SurgeryPhase 1/2NCT00225446

Micron Tracker: Computer-Assisted Orthognathic Surgery With a Third Generation Optic Repositioning System

A Phase 1/2 study testing MicronTracker in people with Computer-Assisted Surgery and Maxillofacial Surgery, run by University Hospital, Grenoble at 1 site in France.

Suspended

Paused. Enrolment is on hold for now and may resume.

Official record
Search all trials

Trial summary

The main objective of this study is to validate a simplified platform of a repositioning system in orthognathic surgery (a third generation optic repositioning system called MicronTracker) compared with the actual clinically validated one (Orthopilot system). Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
MicronTracker
Type of treatment
Medical device
How many people
20 participants
Where
1 siteFrance
Study dates
Feb 2006to Jan 2009
Phase
Phase 1/2
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Mandibular orthognathic surgery

Who cannot join

  • Age <18 years

Trial locations and contacts

1 site in 1 country.

France1 site
  • Maxillofacial and Plastic Surgery Department - University Hospital of Grenoble

    Grenoble, 38043

Other trials in France

About this study

Official title: Computer-Assisted Orthognathic Surgery With a Third Generation Optic Repositioning System.

The main objective of this study is to validate a simplified platform of a repositioning system in orthognathic surgery (a third generation optic repositioning system called MicronTracker) compared with the actual clinically validated one (Orthopilot system).

Read the detailed description

For the past 10 years, the use of computer-assisted surgery has expanded and is now widely spread in the orthopaedic domain, but not in maxillary-facial surgery. The main disadvantages of this technique are the necessity to fix a mark on the eyebrow with two transcutaneous pins, which is a long and invasive act, and to connect the infrared transmitter which is in contact with the patient with the computer in a limited surgery area. In this study, we want to show that the new repositioning optic systems are performing similarly to the actual validated one, that they permit to suppress the transcutaneous pins and the computer connection, and that it reduces the financial cost of this surgery. Neither the surgery technique, nor the pre-operative check-up will be modified in the study. The two repositioning systems will be used simultaneously during the mandibular osteotomy.

Being tested
MicronTracker
Keywords
Orthognathic surgery., optic repositioning system.

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • MicronTrackerDevice

    MicronTracker is a Third Generation Optic Repositioning System in orthognatic surgery.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. spatial coordinates of the target (3 translations and 3 rotations)

    Measured: during surgery

Secondary outcomes (4)
  1. time to install the eyebrow mark with each technique.

    Measured: during surgery

  2. adverse events due to the transcutaneous pins.

    Measured: during surgery

  3. number of handling realized by the nurse for each technique.

    Measured: during surgery

  4. evaluation of cost: number of cable versus number of marker.

    Measured: during surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Sep 2005 (estimated)
  2. Study startFeb 2006
  3. Primary completionJan 2009 (estimated)
  4. Study completionJan 2009 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 1/2
Allocation
Non-randomised
Intervention model
Single group
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
20 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00225446
Sponsor's protocol ID
DCIC 04 14
Status last verified
Jun 2008
First submitted
22 Sep 2005
Last updated
4 Jun 2008
Results posted
No

Publications

  • Bettega G, Cinquin P, Lebeau J, Raphael B. Computer-assisted orthognathic surgery: clinical evaluation of a mandibular condyle repositioning system. J Oral Maxillofac Surg. 2002 Jan;60(1):27-34; discussion 34-5. doi: 10.1053/joms.2002.29069.

    PubMed 11757002
  • Bettega G, Dessenne V, Raphael B, Cinquin P. Computer-assisted mandibular condyle positioning in orthognathic surgery. J Oral Maxillofac Surg. 1996 May;54(5):553-8. doi: 10.1016/s0278-2391(96)90630-8.

    PubMed 8632238
  • Dessenne V. Gestes médico-chirurgicaux assistés par ordinateur: applications à la ligamentoplastie du genou et à la chirurgie orthognatique. Thèse de Génie biologique et médical, Grenoble 1996

  • Bettega G. La chirurgie orthognatique assistée par ordinateur: de la planification à la réalisation. Thèse de Génie biologique et médical, Grenoble 1997

Questions about this trial

What is this clinical trial studying?

A Phase 1/2 study testing MicronTracker in people with Computer-Assisted Surgery and Maxillofacial Surgery, run by University Hospital, Grenoble at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: paused, as of the sponsor's last update on 4 Jun 2008. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this combined phase mean?

Phase 1 studies test a treatment in a small group of people for the first time or in a new way, mainly to check safety and find the right dose.

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

spatial coordinates of the target (3 translations and 3 rotations) (time frame: during surgery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00225446, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Jun 2008.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in